Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC

Clinical trial NCT04983550 · UNKNOWN

Trial details

NCT number: NCT04983550
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2021-09-01
Primary completion: 2023-01-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.